Navigation Links
Suppression of Enzyme Delays a Type of Breast Cancer

Canadian researchers have disclosed that suppression of an enzyme called PTP1B stalls the advancement of a specific type of breast cancer//. This study was conducted on laboratory mice which were genetically modified to develop into a breast cancer condition of humans.

This research headed by Michel L.Tremblay along with Sophie Julien of McGill cancer Center, Quebec delayed the advancement of a particular kind of breast cancer linked to ERBB2 gene. In this case, the breast tumor appeared almost eight weeks later and lung metastases did not happen. In some mice cancer did not develop at all.

On the other hand, when the enzyme PTP1B was expressed it resulted in the development of cancer. Understanding of the relationship between this enzyme and breast cancer is likely to go a long way in treatment of this disease.

Clinical trials of a drug with inhibitory reaction to this protein are underway. There is already a research finding which claims that diabetes 2 and obesity can be treated by this enzyme suppression. In addition to this, PTP1B inhibitors have been developed by drug companies too.

Testing of this inhibitor on humans could begin by 2008. These inhibitors alone or along with another drug could be used in the treatment of breast cancer patients. Currently Herceptin or Trastuzumab is being used.

According to these scientists though there is lot of work to be done in this field, this finding is sure to have a positive impact on further research in this topic.


JYT
'"/>




Page: 1

Related medicine news :

1. Adrenal Suppression not predicted by inhaled corticosteroids
2. Transplant Cures Rats’ Type 2 Diabetes without Need for Immune Suppression Drug
3. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
4. Should Menstrual Suppression Be a Lifestyle Choice?
5. Enzyme may be target for obesity drugs
6. Researchers trick Alzheimers Enzyme
7. Enzyme stimulates growth of adult stem cells
8. Enzyme may aid hold back disease
9. Enzyme help destroy cancer cell
10. Enzyme Associated with Memory
11. Enzyme Associated With Memory
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: